Problems with management of medications create potential for unnecessary suspension of surgery. Spanish researchers have recently demonstrated that cancellation of elective surgical procedures due to inadequate management of chronic medications can be reduced with...
The US FDA has issued a warning advising of an apparent increased risk of pulmonary embolus during treatment with tofacitinib for rheumatoid arthritis (RA) at a dose of a 10 mg twice daily (the FDA has not approved this dosage regimen for RA, this dose is only...
The US FDA has taken thee step of commenting regarding an increased risk of death during treatment with febuxostat, compared to the widely prescribed and well-established alternative agent, allopurinol. Patients are advised to inform health care professionals about a...
Data are from 35 000 parent-child pairs, controlling for parental and adolescent use of other drugs, attitudes about drug use, parental and adolescent psychosocial risk factors, and sociodemographic characteristics, has found that non-medicinal use of prescription...